` ALMD (Allmed Solutions Ltd) vs Tel Aviv 355 Comparison - Alpha Spread

ALMD
vs
Tel Aviv 355

Over the past 12 months, ALMD has underperformed Tel Aviv 355, delivering a return of -19% compared to the Tel Aviv 355's 32% growth.

Stocks Performance
ALMD vs Tel Aviv 355

Loading
No Stocks Selected

Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.

Select Stock to Compare

Performance Gap
ALMD vs Tel Aviv 355

Loading
ALMD
Tel Aviv 355
Difference

Performance By Year
ALMD vs Tel Aviv 355

Loading
ALMD
Tel Aviv 355
Add Stock
No Stocks Selected

Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.

Select Stock to Compare

Competitors Performance
Allmed Solutions Ltd vs Peers

Tel Aviv 355
ALMD
7741
ALC
COLO B
ALGN
Add Stock
No Stocks Selected

Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.

Select Stock to Compare

Allmed Solutions Ltd
Glance View

Market Cap
36.6m ILS
Industry
Health Care

Allmed Solutions Ltd. engages in the development, manufacture, and marketing of minimally invasive products internationally in various medical disciplines. Its products are used by physicians to treat a number of diseases and patients worldwide. The firm's product lines include: Covered Stents, which offers Ureteral Stent (URS), Round Posterior Stent (RPS), Triangular Prostatic Stent (TPS), Bulbar Stent (BUS) and Biliary Stent (BIS); Uro-Gynecology, which offers EndoFast Reliant System, EndoFast Resorb, EndoFast Reliant MN and EndoFast Reliant SCP; Type II Diabetes, which offers the Gastro-duodenal sleeve (GDS), as well as Cardiovascular, which offers WIRION EPD System. The firm's products serve patients with the following medical conditions: Pelvic Organ Prolapse (POP), Sacrocolpopexy, Male Stress Urinary Incontinence (SUI), Urethral/Ureteral Stricture, Carotid Stenosis, Biliary Stricture and Type II Diabetes.

ALMD Intrinsic Value
52.71 ILS
Undervaluation 36%
Intrinsic Value
Price
A
Back to Top